Ross Levine Lab
258 posts


Congratulations, Dr. Michael Waarts, aka LuigiBear, Ph.D., on the successful defense of your outstanding thesis work on characterizing novel CH dependencies (now in press @CD_AACR)! aacrjournals.org/cancerdiscover…


English
Ross Levine Lab retweetledi

Now online in @CD_AACR: JAK2 V617F Reversible Activation Shows Its Essential Requirement in #MyeloproliferativeNeoplasms - by Andrew Dunbar, @bowman_rl, @rosslevinemd, @RossLevineLab and colleagues doi.org/10.1158/2159-8… @MSKCancerCenter #mpnsm

English
Ross Levine Lab retweetledi
Ross Levine Lab retweetledi

Our commentary from the @TrowbridgeLab and @RossLevineLab on the latest clonal hematopoiesis (CH) associated condition 🧠 and it's implications for the study of CH and other aging associated diseases👇
Congrats to @jaiswalmdphd and colleagues!
English
Ross Levine Lab retweetledi

In the Spotlight—
Oncogenic #IDH1 mutation imparts therapeutically targetable metabolic dysfunction in multiple tumor types, by @troymrobinson and @rosslevinemd.
bit.ly/3HQp9bu
@RossLevineLab @MSKCancerCenter

English
Ross Levine Lab retweetledi

Looking forward to moderating a great #ASH22 session with @bowman_rl (I mean who else would I be paired with) on MRD and Single Cell Techniques! 4:30 in Theater C - see you there!

English
Ross Levine Lab retweetledi

Excited to share our latest work published today @CD_AACR: Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
aacrjournals.org/cancerdiscover…
@JianXuLab @CRI_UTSW @UTSWNews
English
Ross Levine Lab retweetledi







